nifedipine has been researched along with Fetal Membranes, Premature Rupture in 13 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Fetal Membranes, Premature Rupture: Spontaneous tearing of the membranes surrounding the FETUS any time before the onset of OBSTETRIC LABOR. Preterm PROM is membrane rupture before 37 weeks of GESTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risk factors for preterm labor commonly observed in the study group were urinary tract infection (60." | 5.39 | Pregnancy outcomes and successful rate of nifedipine therapeutic protocol implementation in a hospital of San Juan. ( Catalano, LN; Negron, I; Rivera Rosa, E; Vázquez Guzmán, M; Villar Diaz, M, 2013) |
| " The aim of this trial was to study the effect of prolonged tocolysis with nifedipine versus placebo in women with PPROM on perinatal outcome and prolongation of pregnancy." | 5.22 | Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial. ( Bax, CJ; Bloemenkamp, KW; de Lange, TS; Franx, A; Kok, M; Mol, BW; Naaktgeboren, CA; Nijman, TA; Oude Rengerink, K; Oudijk, MA; Scheepers, HC; van Eyck, J; van Vliet, EO; Woiski, M, 2016) |
| "To analyse the expression of 15 genes encoding receptors and enzymes associated with the molecular mechanism of the tocolytic drugs atosiban (oxytocin receptor antagonist), nifedipine (calcium channel blocker) and celecoxib (selective cyclo-oxygenase-2 inhibitor) in preterm labor patients with premature rupture of fetal membranes in relation to symptoms of intrauterine infection and preterm labor risk factors." | 3.78 | Expression of selected genes in preterm premature rupture of fetal membranes. ( Chyczewski, L; Kowalczuk, O; Kuć, P; Laudański, P; Laudański, T, 2012) |
| "Risk factors for preterm labor commonly observed in the study group were urinary tract infection (60." | 1.39 | Pregnancy outcomes and successful rate of nifedipine therapeutic protocol implementation in a hospital of San Juan. ( Catalano, LN; Negron, I; Rivera Rosa, E; Vázquez Guzmán, M; Villar Diaz, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Lorthe, E | 1 |
| Kayem, G | 1 |
| Emeruwa, UN | 1 |
| Krenitsky, NM | 1 |
| Sheen, JJ | 1 |
| Kutuk, MS | 1 |
| Ozgun, MT | 1 |
| Uludag, S | 1 |
| Dolanbay, M | 1 |
| Yildirim, A | 1 |
| Catalano, LN | 1 |
| Villar Diaz, M | 1 |
| Vázquez Guzmán, M | 1 |
| Negron, I | 1 |
| Rivera Rosa, E | 1 |
| Mackeen, AD | 2 |
| Seibel-Seamon, J | 2 |
| Muhammad, J | 1 |
| Baxter, JK | 2 |
| Berghella, V | 2 |
| Khoo, F | 1 |
| Mathur, M | 1 |
| van Vliet, E | 1 |
| Seinen, L | 1 |
| Roos, C | 1 |
| Schuit, E | 1 |
| Scheepers, H | 1 |
| Bloemenkamp, K | 1 |
| Duvekot, JJ | 1 |
| van Eyck, J | 2 |
| Kok, JH | 1 |
| Lotgering, FK | 1 |
| van Baar, A | 1 |
| van Wassenaer-Leemhuis, AG | 1 |
| Franssen, MT | 1 |
| Porath, MM | 1 |
| van der Post, J | 1 |
| Franx, A | 2 |
| Mol, B | 1 |
| Oudijk, MA | 2 |
| Nijman, TA | 1 |
| van Vliet, EO | 1 |
| Naaktgeboren, CA | 1 |
| Oude Rengerink, K | 1 |
| de Lange, TS | 1 |
| Bax, CJ | 1 |
| Bloemenkamp, KW | 1 |
| Kok, M | 1 |
| Scheepers, HC | 1 |
| Woiski, M | 1 |
| Mol, BW | 1 |
| Grimes-Dennis, J | 1 |
| Kuć, P | 1 |
| Laudański, P | 1 |
| Kowalczuk, O | 1 |
| Chyczewski, L | 1 |
| Laudański, T | 1 |
| Loi, K | 1 |
| Tan, KT | 1 |
| Nassar, AH | 1 |
| Ghazeeri, G | 1 |
| Usta, IM | 1 |
| Papatsonis, DN | 1 |
| Van Geijn, HP | 1 |
| Adèr, HJ | 1 |
| Lange, FM | 1 |
| Bleker, OP | 1 |
| Dekker, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation: a Double-blinded Randomized Controlled Trial[NCT03976063] | Phase 3 | 850 participants (Anticipated) | Interventional | 2019-10-07 | Recruiting | ||
| Nifedipine Compared to Atosiban for Treating Preterm Labor. A Randomized Controlled Trial.[NCT00599898] | Phase 4 | 145 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for nifedipine and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
Advances in Management for Preterm Fetuses at Risk of Delivery.
Topics: Anti-Bacterial Agents; Anticonvulsants; Betamethasone; Dexamethasone; Female; Fetal Membranes, Prema | 2020 |
Tocolytics for preterm premature rupture of membranes.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Bacterial Agents; Female; Fetal Membranes, P | 2014 |
Tocolytics for preterm premature rupture of membranes.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Bacterial Agents; Female; Fetal Membranes, P | 2011 |
4 trials available for nifedipine and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
Topics: Administration, Oral; Double-Blind Method; Female; Fetal Membranes, Premature Rupture; Gestational A | 2021 |
Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Fetal Membranes, Premature Rupture; Follow | 2016 |
Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
Topics: Adult; Female; Fetal Membranes, Premature Rupture; Humans; Nifedipine; Obstetric Labor, Premature; P | 2016 |
Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial.
Topics: Administration, Oral; Adult; Female; Fetal Membranes, Premature Rupture; Humans; Infusions, Intraven | 1997 |
6 other studies available for nifedipine and Fetal Membranes, Premature Rupture
| Article | Year |
|---|---|
Acute pulmonary failure due to pulmonary edema during tocolytic therapy with nifedipine.
Topics: Acute Disease; Adult; Female; Fetal Membranes, Premature Rupture; Humans; Nifedipine; Obstetric Labo | 2013 |
Pregnancy outcomes and successful rate of nifedipine therapeutic protocol implementation in a hospital of San Juan.
Topics: Adolescent; Adult; Dexamethasone; Drug Administration Schedule; Drug Evaluation; Female; Fetal Membr | 2013 |
Severe resistant maternal hypotension following tocolysis with nifedipine.
Topics: Adolescent; Cesarean Section; Female; Fetal Membranes, Premature Rupture; Fluid Therapy; Gestational | 2014 |
Expression of selected genes in preterm premature rupture of fetal membranes.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Celecoxib; Cyclooxygenase 2 Inhibitors; D | 2012 |
Massive pre-placental and subchorionic haematoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Female; Fetal Membranes, Premature Rupture; Hematoma; | 2006 |
Nifedipine-associated pulmonary complications in pregnancy.
Topics: Adrenal Cortex Hormones; Female; Fetal Membranes, Premature Rupture; Fluid Therapy; Humans; Nifedipi | 2007 |